Cordatus Wealth Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,316
Closed -$306K 187
2025
Q4
$306K Buy
6,316
+1,913
+43% +$94.8K 0.07% 140
2025
Q3
$208K Sell
4,403
-3,811
-46% -$184K 0.05% 159
2025
Q2
$397K Sell
8,214
-214
-3% -$10.9K 0.1% 125
2025
Q1
$467K Buy
8,428
+1,072
+15% +$58K 0.13% 111
2024
Q4
$355K Sell
7,356
-5
-0.1% -$254 0.09% 118
2024
Q3
$424K Hold
7,361
0.15% 95
2024
Q2
$357K Sell
7,361
-5
-0.1% -$241 0.13% 99
2024
Q1
$358K Buy
+7,366
New +$360K 0.26% 46
2023
Q4
Sell
-8,601
Closed -$461K 60
2023
Q3
$461K Sell
8,601
-925
-10% -$49.3K 0.42% 38
2023
Q2
$513K Buy
+9,526
New +$513K 0.19% 84

Other funds holding SNY

Cordatus Wealth Management's SNY Position: Q1 2026 in Review

Cordatus Wealth Management sold out of Sanofi (SNY) in Q1 2026, closing a stake of 6,316 shares — an estimated $306K sold.

Cordatus Wealth Management first reported a position in SNY in Q2 2023 and held it in 10 quarters. The position peaked at $513K in Q2 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Cordatus Wealth Management reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
  • Cordatus Wealth Management sold 6,316 Sanofi shares in Q1 2026, an estimated $306K.
  • Cordatus Wealth Management first reported a position in Sanofi in Q2 2023 and held it in 10 quarters.
  • Cordatus Wealth Management's Sanofi position peaked at $513K in Q2 2023.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Cordatus Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.